SUBSCRIBE
SUBSCRIBE
News   Business

Micrus Endovascular Corporation Second Quarter Results Feature Revenues Up 137%

November 13, 2006 | 
1 min read

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq:MEND) today announced financial results for the three and six months ended September 30, 2006 and raised fiscal 2007 revenue guidance.

Earnings
MORE ON THIS TOPIC
Podcast
RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market
February 5, 2025
 · 
1 min read
 · 
Heather McKenzie
Illustration of two hands shaking while another hand gently grips a wrist
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
February 5, 2025
 · 
8 min read
 · 
Tristan Manalac
Illustration of a computer choosing from a display
Opinion
Pharma M&A Uptick Ushers in a New Era of Data Integration
February 5, 2025
 · 
4 min read
 · 
Raj Indupuri
Brussels, Belgium. 21st December 2020. Exterior view of Pfizer Pharmaceutical company's offices.
Earnings
Pfizer Eyes Deals up to $15B, With ‘Fruitful’ China Discussions Ongoing
February 4, 2025
 · 
4 min read
 · 
Annalee Armstrong